Category: reconsiders
-
AstraZeneca’s £450 million vaccine plant at risk as government reconsiders financial backing
•
The US Treasury has confirmed it remains in “positive discussions” with AstraZeneca over the pharmaceutical giant’s proposed £450m vaccine manufacturing facility in northwest England. However, doubts have emerged following reports that the government is considering cutting its financial support for the project to £40m – a significant cut from the…